Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Head and Neck Cancer

Free Subscription 14.11.2022 3 Am J Gastroenterol 3 BMC Cancer 1 Clin Nucl Med 3 Head Neck 1 Ophthalmic Plast Reconstr Surg 3 Oral Oncol 1 PLoS One 4 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. RUBENSTEIN JH
   Gastroesophageal Reflux Disease Is Not a Great Screening Criterion: Time to Move on to Other Strategies for Controlling the Burden of Esophageal Adenocarcinoma.
   Am J Gastroenterol. 2022;117:1759-1761.
   PubMed         Abstract available
   
   
2. RAJENDRA S
   Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.
   Am J Gastroenterol. 2022;117:1880.
   PubMed        
   
   
3. ELURI S, Reddy S, Ketchem CC, Tappata M, et al
   Low Prevalence of Endoscopic Screening for Barrett's Esophagus in a Screening-Eligible Primary Care Population.
   Am J Gastroenterol. 2022;117:1764-1771.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. WANG L, Yao B, Yang J, Tian Z, et al
   Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
   BMC Cancer. 2022;22:1131.
   PubMed         Abstract available
   
   
5. CARPEN T, Gille E, Hammarstedt-Nordenvall L, Hansen J, et al
   Occupational risk variation of nasopharyngeal cancer in the Nordic countries.
   BMC Cancer. 2022;22:1130.
   PubMed         Abstract available
   
   
6. INOKAWA Y, Hayashi M, Begum S, Noordhuis MG, et al
   High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.
   BMC Cancer. 2022;22:1146.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

7. XU T, Zhang Y, Wu R, Ding H, et al
   68Ga-DOTA-FAPI-04 PET/CT Imaging in a Case of Radioactive Iodine-Induced Chronic Parotitis.
   Clin Nucl Med. 2022;47:1082-1083.
   PubMed         Abstract available
   
   

   
   Head Neck

8. GIANNITTO C, Mercante G, Ammirabile A, Cerri L, et al
   Radiomics-based machine learning for the diagnosis of lymph node metastases in patients with head and neck cancer: Systematic review.
   Head Neck. 2022 Nov 8. doi: 10.1002/hed.27239.
   PubMed         Abstract available
   
   
9. YEH CF, Lee WY, Yu TH, Hsu YB, et al
   Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma.
   Head Neck. 2022 Nov 8. doi: 10.1002/hed.27238.
   PubMed         Abstract available
   
   
10. GIRARDI FM, Wagner VP, Martins MD, Abentroth AL, et al
    Impact of AJCC 8 pT staging in cutaneous head and neck squamous cell carcinoma in a nonselected real-world patient sample.
    Head Neck. 2022 Nov 7. doi: 10.1002/hed.27233.
    PubMed         Abstract available
    
    

    
    Ophthalmic Plast Reconstr Surg

11. ROSE GE, Vahdani K, Lewis J, Rose AM, et al
    Risk and Lag-time for Development of Lacrimal Gland Carcinoma Expleomorphic Adenoma: Observations and Conjectural Study.
    Ophthalmic Plast Reconstr Surg. 2022;38:563-566.
    PubMed         Abstract available
    
    

    
    Oral Oncol

12. BISHESHAR SK, van der Kamp MF, de Ruiter EJ, Ruiter LN, et al
    The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Oral Oncol. 2022;135:106227.
    PubMed         Abstract available
    
    
13. QUAN T, Guan W, Huang W, Cui C, et al
    Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma.
    Oral Oncol. 2022;135:106230.
    PubMed         Abstract available
    
    
14. KMIECIK M, Nogal P, Banaszewski J, Wierzbicka M, et al
    Corrigendum to "Anterolateral thigh free flap reconstruction of pharyngoesophageal defect caused by radiotherapy for laryngeal cancer: A case report" [Oral Oncol. 134 (2022) 106135].
    Oral Oncol. 2022 Nov 4:106233. doi: 10.1016/j.oraloncology.2022.106233.
    PubMed        
    
    

    
    PLoS One

15. LIN CH, Chuang HN, Hsiao TH, Kumar VB, et al
    AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma.
    PLoS One. 2022;17:e0276990.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

16. ZHONG Z, Wang D, Liu Y, Shao S, et al
    Lymph Drainage and Cervical Fascia Anatomy-Oriented Differential Nodal CTV Delineation at the Supraclavicular Region for Esophageal Cancer and Nasopharyngeal Cancer.
    Radiother Oncol. 2022 Nov 3. pii: S0167-8140(22)04531.
    PubMed        
    
    
17. CHOW JCH, Lui JCF, Cheung KM, Tam AHP, et al
    Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
    Radiother Oncol. 2022 Nov 3. pii: S0167-8140(22)04529.
    PubMed         Abstract available
    
    
18. HUANG H, Miao J, Zhao C, Wang L, et al
    Response to Gargi S Sarode, Sachin C Sarode, and Rahul Anand's Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing inten
    Radiother Oncol. 2022 Nov 2. pii: S0167-8140(22)04517.
    PubMed        
    
    
19. SARODE GS, Sarode SC, Anand R
    Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective pha
    Radiother Oncol. 2022 Nov 2. pii: S0167-8140(22)04515.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: